Physician profile
Jeff M Sloyer
NPI 1215931175
$5,028.85
in general payments reported to CMS, 2019-2025
41 companies · $519 in 2025
The $519 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $774 · 2020: $257 · 2021: $415 · 2022: $1,578 · 2023: $776 · 2024: $709 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,004.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $794.84 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Novo Nordisk INC | $714.51 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Otsuka America Pharmaceutical, INC. | $418.65 | 2022-2025 | Rexulti, Abilify Maintena |
| Lilly USA, LLC | $308.08 | 2019-2024 | Mounjaro, Zepbound |
| Amgen INC. | $298.68 | 2019-2025 | Evenity, Prolia, Repatha |
| Allergan, INC. | $193.83 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $188.39 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $167.26 | 2021-2022 | |
| Abbott Laboratories | $158.76 | 2022-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $130.60 | 2022 | |
| Pfizer INC. | $116.56 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $112.33 | 2019-2022 | |
| Axsome Therapeutics, INC. | $111.61 | 2023-2025 | Auvelity, Sunosi |
| E.R. Squibb & Sons, L.L.C. | $110.06 | 2019-2023 | Eliquis |
| Merck Sharp & Dohme LLC | $109.07 | 2021-2025 | Capvaxive, Gardasil 9, Gardasil |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Sloyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.